In our published and current studies, we have demonstrated strategies for reprogramming the GBM-associated Iba1+ TAMs from the Arg1high, iNOSlow tumor-promoting M2-like state to the tumoricidal Arg1low, iNOShigh M1-like state. The gene discussed is AIF1; the disease is neoplasm.